OSENI - 64764-251-06 - (alogliptin and pioglitazone)

Alphabetical Index


Drug Information of OSENI

Product NDC: 64764-251
Proprietary Name: OSENI
Non Proprietary Name: alogliptin and pioglitazone
Active Ingredient(s): 25; 15    mg/1; mg/1 & nbsp;   alogliptin and pioglitazone
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of OSENI

Product NDC: 64764-251
Labeler Name: Takeda Pharmaceuticals America, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022426
Marketing Category: NDA
Start Marketing Date: 20130125

Package Information of OSENI

Package NDC: 64764-251-06
Package Description: 4 CARTON in 1 TRAY (64764-251-06) > 1 BLISTER PACK in 1 CARTON > 7 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of OSENI

NDC Code 64764-251-06
Proprietary Name OSENI
Package Description 4 CARTON in 1 TRAY (64764-251-06) > 1 BLISTER PACK in 1 CARTON > 7 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 64764-251
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name alogliptin and pioglitazone
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130125
Marketing Category Name NDA
Labeler Name Takeda Pharmaceuticals America, Inc.
Substance Name ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Strength Number 25; 15
Strength Unit mg/1; mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of OSENI


General Information